IRCCS Istituto Ortopedico Galeazzi
Milan, Italy
NCT Number: NCT04197804
The study intends to evaluate the role of Mirror Neurons in the determination of gestures, words, and repetitive vocalizations in subjects affected by Tourette's syndrome and to verify if these subjects are faster to assemble sounds, in phonology and morphology, than the non-pathological population.
Looking for future studies?
Notify Me6 year–10 year
All sexes
Observational
Milan, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
TOURETTE GROUP
NOT GROUP TOURETTE
Exclusion criteria
TOURETTE GROUP
NOT GROUP TOURETTE
The subjects of the Tourette group and control group are subjected to routine tests performed at Tourette Center and Extrapyramidal Diseases. Both groups are initially subjected to an evaluation that aims to identify the IQ and therefore 4 tasks are presented. The 1st (with a duration of about 2 and a half minutes) and the 2nd (with a duration of about 2 minutes) related to the motor field, the 3rd (with duration of about 1 minute) and the 4th (with duration about 3 minutes) the language field. These evaluations are in practice at the Center for Tourette patients; the tasks will be administered to both groups.
Time frame: Through study completion, an average of 1 year
The aim is to investigate the correlation between Mirror Neurons and Tourette Syndrome defining the greater propensity of the Tourettian subjects to imitate gestures, through the administration of the first Task
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Other
Do Mirror Neurons Play a Role in Tourette Syndrome Physiopathology? A Pilot Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05269953
Basal Ganglia Diseases, Brain Diseases
Nottingham, Nottinghamshire, United Kingdom
View Trial DetailsNCT03604510
Basal Ganglia Diseases, Brain Diseases
Bordeaux, France
View Trial DetailsNCT05628805
Basal Ganglia Diseases, Brain Diseases
Cincinnati, Ohio, United States
View Trial DetailsNCT04978428
Anxiety Disorders, Basal Ganglia Diseases
Chicago, Illinois, United States
View Trial Details